Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study
Journal of Global Health · 2025
DOI: 10.7189/jogh.15.04075 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Global Health, 2025. Verfasst von Farzana Afroze und 19 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Hauptthemen laut MEDLINE: COVID-19, Survivors, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In developing settings, comparative data on COVID hospitalised survivors (HS) and non-hospitalised survivors (NHS) is scarce. We determined burdens, incidence, evolution, and associated factors of long COVID-19 over two years among these groups.
Methods
We conducted a longitudinal cohort study in Dhaka, Bangladesh, and recruited confirmed COVID-19 survivors from December 2020 to May 2021 (previously reported). 346 survivors underwent in-person follow-ups at five, nine, 18 months and two years post-infection. The assessment included long COVID symptoms, cardiorespiratory function, neuropsychiatric conditions, quality of life, and laboratory tests. The outcomes included one or more symptoms and/or signs indicative of long COVID, aligning closely with the World Health Organization definition of post-COVID-19 condition.
Results
Of the 346 participants, we included 326 in the analysis. 78% of HS (n/N = 171/219) and 62% of NHS (n/N = 55/89) reported at least one sequela symptom. HS had higher odds of palpitations, headaches, dizziness, sleeping difficulties, brain fog, muscle weakness, joint pain, hypertension, insulin requirement, poor quality of life, and prolonged corrected QT intervals on electrocardiogram compared to NHS at two years (95% confidence interval (CI)>1). Regarding evolution, sequelae-symptoms, neurological outcomes, restrictive spirometry findings, and electrocardiogram abnormalities remained unchanged, although psychiatric sequelae, quality of life, and exercise capacity improved in both groups. Hospital readmission rates significantly increased (P 1). Two or more vaccine doses decreased the risk of respiratory (adjusted risk ratio (aRR) = 0.76; 95% CI = 0.63-0.91) and psychiatric sequelae (aRR = 0.78; 95% CI = 0.66-0.92) than one or no doses.
Conclusions
COVID-19 survivors, particularly HS, experienced a higher burden of persistent symptoms and health issues two years after infection. However, vaccination significantly reduced the risk of respiratory and psychiatric outcomes. These findings highlight the importance of ongoing vaccination programs and the need for targeted rehabilitation services in low-resource settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
- Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
- Department of Cardiology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
- Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Zitieren
APA
Afroze, F., Arafat, S. M., Ahmed, C. M., Alam, B., Banu, S., Islam, M. Z., Mahfuz, M., Qadri, F., Bhuiyan, T. R., Parvin, I., Ackhter, M. M., Islam, F., Sultana, M., Sultana, E., Rahaman, M. F. U., Khan, A. H., Hasan, M. N., Ahmed, S., Chisti, M. J., & Ahmed, T. (2025). Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study. Journal of Global Health. https://doi.org/10.7189/jogh.15.04075
Vancouver
Afroze F, Arafat SM, Ahmed CM, Alam B, Banu S, Islam MZ, et al. Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study. Journal of Global Health. 2025. doi:10.7189/jogh.15.04075
BibTeX
@article{Afroze2025,
author = {Afroze, Farzana and Arafat, Shohael Mahmud and Ahmed, Chowdhury Meshkat and Alam, Baharul and Banu, Sayera and Islam, Md Zahidul and Mahfuz, Mustafa and Qadri, Firdausi and Bhuiyan, Taufiqur Rahman and Parvin, Irin and Ackhter, Mst Mahmuda and Islam, Farhana and Sultana, Monjeline and Sultana, Eva and Rahaman, Mohammad Ferdous Ur and Khan, Abed Hussain and Hasan, Md Nazmul and Ahmed, Shahriar and Chisti, Mohammod Jobayer and Ahmed, Tahmeed},
title = {Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study},
journal = {Journal of Global Health},
year = {2025},
doi = {10.7189/jogh.15.04075}
}
EUVIMED